Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication

Journal of Chemical Information and Computer Sciences

Volumn 41, Issue 6, 2001, Pages 1578-1586

  Ekins, Sean ^a   Durst, Gregory L ^a   Stratford, Robert E ^a   Thorner, David A ^a   Lewis, Richard ^a   Loncharich, Richard J ^a   Wikel, James H ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPROXIMATION THEORY; CHEMICAL BONDS; MECHANICAL PERMEABILITY; MOLECULAR STRUCTURE; VIRUSES;

GENETIC FUNCTION APPROXIMATION (GFA);

ENZYMES;

ANTIVIRUS AGENT;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; PHYSIOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RHINOVIRUS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; HUMAN; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RHINOVIRUS; VIRUS REPLICATION;

EID: 0035514751     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci010330i     Document Type: Article

References (46)

1. Grass, G. M. Simulation models to predict oral drug absorption from in vitro data. Adv Drug. Del. Rev. 1997, 23, 199-219.
2. Barthe, L.; Woodley, J.; Houin, G. Gastrointestinal absorption of drugs: methods and studies. Fundam. Clin. Pharmacol. 1999, 13, 154-168.
3. Irvine, J. D.; Takahashi, L.; Lockhart, K.; Cheong, J.; Tolan, J. W.; Selick, H. E.; Grove, J. R. MDCK (Madin-Darby Canine Kidney) cells: a tool for membrane permeability screening, J. Pharm. Sci. 1999, 88, 28-33.
4. Kramer, S. D. Absorption prediction from physicochemical parameters. Pharm. Sci. Technol. Today, 1999, 2, 373-380.
5. Egan, W. J.; Merz, K. M. J.; Baldwin, J. J. Prediction drug absorption using multivariate statistics. J. Med. Chem. 2000, 43, 3867-3877.
6. van de Waterbeemd, H.; Camenenisch, G.; Folkers, G.; Raevsky, O. A. Estimation of Caco-2 cell permeability using calculated molecular descriptors. Quant. Struct. Act. Relat. 1996, 15, 480-490.
7. Segarra, V.; Lopez, M.; Ryder, H.; Palacios, J. M. Prediction of drug permeability based on GRID calculations. Quant. Struct. Act. Relat. 1999, 18, 474-481.
8. Bravi, G.; Wikel, J. H. Application of MS-WHIM Descriptors: 3, Prediction of molecular properties, Quant. Struct. Act. Relat. 2000, 19, 39-49.
9. Clark, D. E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. prediction of intestinal absorption. J. Pharm. Sci. 1999, 88, 807-814.
10. Kelder, J.; Grootenhuis, P. D. J.; Bayada, D. M.; Delbressine, L. P. C.; Ploemen, J.-P. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs, Pharm. Res. 1999, 16, 1514-1519.
11. Krarup, L. H.; Christensen, I. T.; Hovgaard, L.; Frokjaer, S. Predicting drug absorption from molecular surface properties based on molecular dynamics simulations. Pharm. Res. 1998, 15, 972-978.
12. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Del. Rev. 1997, 23, 3-25.
13. Norinder, U.; Osterberg, T.; Artursson, P. Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. Eur. J. Pharm. Sci. 1999, 8, 49- 56.
14. Palm, K.; Luthman, K.; Ungell, A.-L.; Strandlund, G.; Artursson, P. Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 1996, 85, 32-39.
15. Palm, K.; Stenberg. P.; Luthman, K.; Artursson, P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 1997, 14, 568-571.
16. Palm, K.; Luthman, K.; Ungell, A.-L.; Strandlund, G.; Beigi, F.; Lundahl, P.; Artursson, P. Evaluation of dynamic polar molecular surface area as a predictor of drug absorption: Comparison with other computational and experimental predictors. J. Med. Chem. 1998, 41, 5382-5392.
17. Sugawara, M.; Takekuma, Y.; Yamada, H.; Kobayashi, M.; Iseki, K.; Miyazaki, K. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physiochemical properties and drug-membrane electrostatic interaction. J. Pharm. Sci. 1998, 87, 960-966.
18. Wessel, M. D.; Jurs, P. C.; Tolan, J. W., Muskal, S. M. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 1998, 38, 726-735.
19. Ekins, S.; Bravi, C.; Binkley, S.; Gillespie, J. S.; Ring, B. J.; Wikel, J. H.; Wrighton, S. A. Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors. Pharmacogenetics 1999, 9, 477-489.
20. Ekins, S.; Bravi, G.; Binkley, S.; Gillespie, J. S.; Ring, B. J.; Wikel, J. H.; Wrighton, S. A. Three-dimensional-quantitative structure activity relationship (3D-QSAR) analyses of inhibitors for CYP3A4. J. Pharmacol. Exp. Thera. 1999, 290, 429-438.
21. Ekins, S.; Bravi, G.; Wikel, J. H.; Wrighton, S. A. Three-dimensional quantitative structure activty relationship (3D-QSAR) analysis of CYP3A4 substrates. J. Pharmacol. Exp. Thera. 1999, 291, 424-433.
22. Ekins, S.; Bravi, G.; Ring, B. J.; Gillespie, T. A.; Gillespie, J. S.; VandenBranden, M.; Wrighton, S. A.; Wikel, J. H. Three-dimensional- quantitative structure activity relationship (3D-QSAR) analyses of substrates for CYP2B6. J. Pharmacol. Exp. Thera. 1999, 288, 21- 29.
23. Ekins, S.; Bravi, G.; Binkley, S., Gillespie, J. S.; Ring, B. J.; Wikel, J. H.; Wrighton, S. A. Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors. Drug. Met. Dispos. 2000, 28, 994-1002.
24. Ekins, S.; Ring, B. J.; Bravi, G.; Wikel, J. H.; Wrighton, S. A. Predicting Drug-drug interactions in silico using pharmacophores: a paradigm for the next millenium; Guner, O. F., Ed.; University International Line: San Diego, 2000; pp 269-299.
25. Stratford, R. E. J.; Clay, M. P.; Heinz, B. A.; Kuhfeld, M. T.; Osborne, S. J.; Philips, D. L.; Sweetana, S. A.; Tebbe, M. J.; Vasudevan, V.; Zornes, L. L.; Lindstrom, T. D. Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication. J. Pharm. Sci. 1999, 88, 747-753.
26. Kuhfeld, M. T.; Stratford, R. E. In vitro measurement of drug transport using a new diffusion chamber compatible with millicell culture supports: performance with Caco-2 monolayers. Int. J. Pharm. 1996, 33, 47-58.
27. Weininger, D. SMILES 1. Introduction and encoding rules. J. Chem. Inf. Comput. Sci. 1988, 28, 31.
28. Cramer, R. D., III.: Patterson, D. E.; Bunce, J. D. 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
29. Bravi, G.; Wikel, J. H. Application of MS-WHIM Descriptors: 1. Introduction of new molecular surface properties and 2. Prediction of binding affinity data, Quant. Struct. Act. Relat. 2000, 19, 29-38.
30. Cruciani, G.; Pastor, M.; Guba, W. Volsurf: a new tool for the pharmokinetic optimization of lead compounds. Eur. J. Pharm. Chem. 2000. 11 suppl 2, S29-S39.
31. Crivori, P.; Cruciani, G.; Carrupt, P. A.; Testa, B. Predicting blood- brain barrier permeation from the three-dimensional molecular structure. J. Med. Chem. 2000, 43, 2204-2216.
32. Goodford, P. J. Computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem. 1985, 28, 849-857.
33. Bobbyer, D. N. A.; Goodford, P. J.; McWhinnie, P. M. New hydrogen- bond potential for use in determining energetically favorable binding sites of molecules of known structure. J. Med. Chem. 1989, 32, 1083- 1094.
34. Stenberg. P.; Luthman, K.; Ellens, H.; Lee, C. P.; Smith, P. L.; Lago, A.; Elliot, J. D.; Artursson, P. Prediction of the intestinal absorption of endothelin receptor antagonists using three theoretical methods of increasing complexity. Pharm. Res. 1999, 16, 1520-1526.
35. Breitkreutz, J. Prediction of intestinal drug absorption properties by three-dimensional solubility parameters. Pharm. Res. 1998, 15, 1370- 1375.
36. Ghuloum, A. M.; Sage, C. R.; Jain, A. N. Molecular haskeys: a novel methods for molecular characterisation and its application for predicting important pharmaceutical properties of molecules. J. Med. Chem. 1999, 42, 1739-1748.
37. Wils, P.; Warnery, A.; Phung-Ba, V.; Scherman, D. Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell. Biol. Toxicol. 1994, 10, 393- 397.
38. Walter, E.; Janich, S.; Roessler, B. J.; Hilfinger, J. M.; Amidon, G. L. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J. Pharm. Sci. 1996, 85, 1070-1076.
39. Curatolo, W. Physical chemical properties of oral drug candidates in the discovery and exploratory development settings. P. S.I.T. 1998, 1, 387-393.
40. Rogers, D.; Hopfinger, A. J. Application of genetic function approximation to quantitative structure-activity relationships and quan titative structure property relationships. J. Chem. Inf. Comput. Sci. 1994, 34, 854-866.
41. So, S.-S.; Karplus, M. Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors. J. Med. Chem. 1996, 39, 5246-5256.
42. So, S.-S.; Karplus, M. A comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors. J. Comput. Aided. Mol. Des. 1999, 13, 243- 258.
43. Hou, T. J.; Wang, J. M.; Liao, N.; Xu, X. J. Applications of genetic algorithms on the structure - activity relationship analysis of some cinnamamides. J. Chem. Inf. Comput. Sci. 1999, 39, 775-781.
44. Ajay On better generalization by combining two or more models: a quantitative structure-activity relationship example using neural networks. Chem. Intel. Lab Sys. 1994, 24, 19-30.
45. Ertl, P.; Rohde, B.; Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 2000, 43, 3714-3717.
46. Stenberg, P. Computational Models for the prediction of intestinal membrane permeability. Ph.D. Thesis, Uppsala University, Uppsala, Sweden, 2001.